This being the case the development of a new medicine has certain fixed costs associated with it. In an effort to reduce the costs and maximize the number of new molecules in development, procedures have been established in all areas in bringing a drug to market. One of these areas is the first screening of molecules for pharmaceutical activity. For the process a methodology referred to as “High Throughput Screening (HTS screening)” utilizes advanced technology to screen, assess and weed out new molecules for pharmaceutical activity [4]. To put it into perspective HTS investigations should be able to average 20 000 compounds per week. To achieve this output various techniques used; combinatorial chemistry, peptide & protein libraries and genomics. A reference search on a reference database for high throughput screening will give approximately 10 000 responses, indicating the significance of these techniques. The are many high throughput screening reviews available for the discerning research to assist in developing individual codes of practice but technology never sleeps and now methodologies are being introduced continuously.